New Research: Cracking The Targeted Drug Resistance Puzzle And Eliminating Cancer Cells Before They Evolve!

UCLA Health University of California, Los Angeles Medical Center.

Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma

Great Ormond Street Hospital for Children

Royal National Orthopaedic Hospital

New TCR-T Therapy Afami-cel For Advanced Sarcoma With Promising And Long-Lasting Results!